1.Recent Advances in the Concept and Pathogenesis of IgG4-Related Disease in the Hepato-Bilio-Pancreatic System.
Kazuichi OKAZAKI ; Masahito YANAGAWA ; Toshiyuki MITSUYAMA ; Kazushige UCHIDA
Gut and Liver 2014;8(5):462-470
Recent studies have proposed nomenclatures of type 1 autoimmune pancreatitis (AIP) (IgG4-related pancreatitis), IgG4-related sclerosing cholangitis (IgG4-SC), IgG4-related cholecystitis, and IgG4-related hepatopathy as IgG4-related disease (IgG4-RD) in the hepato-bilio-pancreatic system. In IgG4-related hepatopathy, a novel concept of IgG4-related autoimmune hepatitis (AIH) with the same histopathological features as AIH has been proposed. Among organs involved in IgG4-RD, associations with pancreatic and biliary lesions are most frequently observed, supporting the novel concept of "biliary diseases with pancreatic counterparts." Targets of type 1 AIP and IgG4-SC may be periductal glands around the bile and pancreatic ducts. Based on genetic backgrounds, innate and acquired immunity, Th2-dominant immune status, regulatory T (Treg) or B cells, and complement activation via a classical pathway may be involved in the development of IgG4-RD. Although the role of IgG4 remains unclear in IgG4-RD, IgG4-production is upregulated by interleukin 10 from Treg cells and by B cell activating factor from monocytes/basophils with stimulation of toll-like receptors/nucleotide-binding oligomerization domain-like receptors. Based on these findings, we have proposed a hypothesis for the development of IgG4-RD in the hepato-bilio-pancreatic system. Further studies are necessary to clarify the pathogenic mechanism of IgG4-RD.
Adaptive Immunity
;
Autoimmune Diseases/*immunology
;
B-Cell Activating Factor/metabolism
;
Cholangitis, Sclerosing/*immunology
;
Cholecystitis/*immunology
;
Humans
;
Immunoglobulin G/*immunology
;
Interleukin-10/metabolism
;
Liver Diseases/*immunology
;
Pancreatitis/*immunology
;
T-Lymphocytes, Regulatory/immunology
2.Deficiencies of Circulating Mucosal-associated Invariant T Cells and Natural Killer T Cells in Patients with Acute Cholecystitis.
Jung Chul KIM ; Hye Mi JIN ; Young Nan CHO ; Yong Soo KWON ; Seung Jung KEE ; Yong Wook PARK
Journal of Korean Medical Science 2015;30(5):606-611
Mucosal-associated invariant T (MAIT) cells and natural killer T (NKT) cells are known to play crucial roles in a variety of diseases, including autoimmunity, infectious diseases, and cancers. However, little is known about the roles of these invariant T cells in acute cholecystitis. The purposes of this study were to examine the levels of MAIT cells and NKT cells in patients with acute cholecystitis and to investigate potential relationships between clinical parameters and these cell levels. Thirty patients with pathologically proven acute cholecystitis and 47 age- and sex-matched healthy controls were enrolled. Disease grades were classified according to the revised Tokyo guidelines (TG13) for the severity assessment for acute cholecystitis. Levels of MAIT and NKT cells in peripheral blood were measured by flow cytometry. Circulating MAIT and NKT cell numbers were significantly lower in acute cholecystitis patients than in healthy controls, and these deficiencies in MAIT cells and NKT cell numbers were associated with aging in acute cholecystitis patients. Notably, a reduction in NKT cell numbers was found to be associated with severe TG13 grade, death, and high blood urea nitrogen levels. The study shows numerical deficiencies of circulating MAIT and NKT cells and age-related decline of these invariant T cells. In addition, NKT cell deficiency was associated with acute cholecystitis severity and outcome. These findings provide an information regarding the monitoring of these changes in circulating MAIT and NKT cell numbers during the course of acute cholecystitis and predicting prognosis.
Aged
;
Antibodies, Monoclonal/immunology
;
Case-Control Studies
;
Cholecystitis, Acute/*diagnosis/immunology/pathology
;
Female
;
Flow Cytometry
;
Humans
;
Leukocytes, Mononuclear/cytology
;
Male
;
Middle Aged
;
Natural Killer T-Cells/*cytology/immunology
;
Patients
;
Prognosis
;
Severity of Illness Index
;
T-Lymphocyte Subsets/*cytology/immunology